Weight loss program
GLP-1 evaluation, labs, ongoing management
About Weight loss program
A medical weight-loss program treats obesity as the chronic disease it is rather than a willpower problem. Evaluation reviews weight history, prior attempts, sleep, mood, medications, and metabolic labs (A1c, lipids, thyroid, liver) to identify reversible contributors and set realistic goals. Modern care combines nutrition, physical activity, and behavioral support with FDA-approved medications — most commonly GLP-1 and GIP/GLP-1 receptor agonists such as semaglutide and tirzepatide, which reduce appetite and improve cardiometabolic risk. Treatment is long-term, not episodic; even 5–10% sustained weight loss meaningfully lowers cardiovascular and diabetes risk.